Safety and Immunogenicity of a Trivalent <i>Salmonella</i> Conjugate Vaccine to <i>S.</i> Typhi, <i>S.</i> Typhimurium, and <i>S.</i> Enteritidis
These data encourage the further development of TSCV to address a pressing public health problem in young children of sub-Saharan Africa.
Authors
- Yujia Liang (ORCID: https://orcid.org/0000-0002-0585-5169)
- James E. Galen (ORCID: https://orcid.org/0000-0003-4202-0213)
- Marcelo B. Sztein (ORCID: https://orcid.org/0000-0001-8282-860X)
- M. M. Levine
- Raches Ella (ORCID: https://orcid.org/0000-0002-4646-4471)
- Raphael Simon (ORCID: https://orcid.org/0000-0002-4136-0948)
- Rezwanul Wahid (ORCID: https://orcid.org/0000-0002-5623-1903)
- Michael J. Sikorski (ORCID: https://orcid.org/0000-0002-3811-7285)
- Krishna M. Ella (ORCID: https://orcid.org/0000-0002-0021-5082)
- Reva Datar
- Charmagne Beckett
- Scott M. Baliban (ORCID: https://orcid.org/0000-0002-2771-1609)
- K. S. Mohan (ORCID: https://orcid.org/0000-0001-6407-7654)
- Andrew Lees
- Marcela F Pasetti
- M Gangadhara Naidu
- D Yogeswara Rao
- Mohamed Al-Ibrahim
- Sharon M Tennant
- Wilbur H Chen
Institutions
- University of Maryland, Baltimore (US)
- Bharat Biotech (India) (IN)
- Pharmaron (United Kingdom) (GB)
- Emergent BioSolutions (United States) (US)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1093/infdis/jiag156
- Primary Topic
- Salmonella and Campylobacter epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00